CT-Based Radiomic Score: A Risk Stratifier in Far-Advanced Gastric Cancer Patients

医学 内科学 置信区间 围手术期 肿瘤科 队列 危险系数 回顾性队列研究 癌症 转移 外科
作者
Lan Wang,Lan Zhu,Jun Yan,Wenxing Qin,Chun Wang,Wenqi Xi,Zhihan Xu,Yong Chen,Jiang Jiang,Shixing Huang,Chao Yan,Huan Zhang,Zilai Pan,Jun Zhang
出处
期刊:Academic Radiology [Elsevier BV]
卷期号:30: S220-S229 被引量:14
标识
DOI:10.1016/j.acra.2022.12.034
摘要

OBJECTIVES: To prolong the survival, the value of a computed tomography-based radiomic score (RS) in stratifying survival and guiding personalized chemotherapy strategies in far-advanced gastric cancer (FGC) was investigated. MATERIALS AND METHODS: This retrospective multicenter study enrolled 283 FGC patients (cT4a/bNxM0-1) from three centers. Patients from one center were randomly divided into the training (n = 166) and internal validation (n = 83) cohorts, whereas the external validation cohort (n = 34) consisted of patients from the two other centers. The RS was calculated for each patient to predict progression-free survival (PFS). Features from the primary tumor and main metastasis (peritoneum, liver, and lymph node) were integrated in the training cohort and then validated for its ability to stratify PFS and overall survival (OS) in the validation cohort. The association between the RS and efficacy of neoadjuvant intraperitoneal and systemic (NIPS) therapy was also explored. RESULTS: The RS demonstrated a favorable prognostic ability to predict PFS in all cohorts (training: C-index 0.83, 95% confidence interval [CI]: 0.788-0.872; internal validation: C-index 0.75, 95% CI: 0.682-0.818; external validation: C-index 0.76, 95% CI: 0.669-0.851; all p < 0.05), as well as an excellent ability to stratify the PFS and OS in both the whole population and metastatic subgroups (p < 0.05). Patients with a low score were more likely to undergo surgery after perioperative chemotherapy (p < 0.05). Furthermore, only high-scoring patients with peritoneal metastasis benefited from NIPS. CONCLUSION: The RS may be an effective risk stratifier for the outcomes of FGC patients and may be used to select patients who can benefit from NIPS therapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
77完成签到,获得积分10
2秒前
眼睛大的小熊猫完成签到,获得积分10
2秒前
清爽难破完成签到 ,获得积分10
4秒前
4秒前
NingCp完成签到,获得积分10
5秒前
5秒前
6秒前
6秒前
6秒前
传奇3的应助被quantu采纳,获得10
6秒前
踏实以松发布了新的文献求助10
6秒前
丘比特的应助被幽凡采纳,获得10
8秒前
林林完成签到 ,获得积分10
9秒前
坚强孤容发布了新的文献求助10
11秒前
11秒前
12秒前
迷你的寄云完成签到,获得积分10
14秒前
14秒前
15秒前
李麟发布了新的文献求助10
15秒前
思源的应助被邵蹦蹦采纳,获得10
16秒前
17秒前
xuejingling发布了新的文献求助10
17秒前
molihuakai的应助被长情豁采纳,获得10
17秒前
科研通AI6.2的应助被123采纳,获得10
17秒前
哈哈客发布了新的文献求助10
19秒前
在水一方的应助被百里采纳,获得10
19秒前
搜集达人的应助被坚强孤容采纳,获得10
20秒前
21秒前
21秒前
Hello的应助被徐XU采纳,获得10
22秒前
七七完成签到 ,获得积分10
22秒前
rongjian完成签到 ,获得积分10
23秒前
人间慈悲的应助被辛勤的西牛采纳,获得10
23秒前
24秒前
24秒前
张二发布了新的文献求助10
26秒前
26秒前
surge发布了新的文献求助10
26秒前
27秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186734
求助须知:如何正确求助?哪些是违规求助? 9575007
关于积分的说明 21839114
捐赠科研通 7784289
什么是DOI,文献DOI怎么找? 3434808
关于科研通互助平台的介绍 2559206
邀请新用户注册赠送积分活动 2481611